Beginning Cash: The amount of cash reported by the company on its previous statement.
Aprea Therapeutics, Inc. (APRE) had Beginning Cash of $14.64M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-4.81M |
|
-- |
|
-- |
|
$5.17M |
|
$-5.17M |
|
$0.36M |
|
$-4.81M |
|
$-4.81M |
|
$-4.81M |
|
$-4.81M |
|
$-4.81M |
|
$-4.81M |
|
$-5.17M |
|
$-5.17M |
|
53.68M |
|
53.68M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$38.44M |
|
$0.06M |
|
$0.38M |
|
$38.81M |
|
$3.97M |
|
-- |
|
$0.73M |
|
$4.70M |
|
$34.11M |
|
$34.11M |
|
$34.11M |
|
14.19M |
|
| Cash Flow Statement Financials | |
$-9.76M |
|
$-0.02M |
|
$33.03M |
|
|
Beginning Cash |
$14.64M |
$37.89M |
|
$23.25M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.10% |
|
-14.10% |
|
-12.39% |
|
-14.10% |
|
$2.40 |
|
$-0.18 |
|
$-0.18 |
|